{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-009432","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2025-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.495537+00:00","generated_at":"2026-05-16T16:53:39.985730+00:00","sec_items":["1.01","1.02","2.03","3.02","5.03","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"confidence":"high","headline":"KALA BIO enters $6M private placement, resolves Oxford default, appoints David Lazar as CEO","bullets":["First closing raised $1.8M from 900k Series AA preferred shares at $2/share; second closing up to $4.2M subject to stockholder approval.","Oxford loan settlement: $2M cash and 1.62M common shares reduce loan by $7M; $1M initial cash due by Jan 15, 2026 or stockholder meeting.","David Lazar appointed CEO and board chair; Mary Reumuth terminated as CFO; Gregory Perry resigns from board.","Company terminated all remaining employees in October after Oxford foreclosure; now resumes operations with limited cash from placement.","Stockholder meeting required before March 31, 2026 to approve share increase and conversion of preferred shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-009432","json":"https://secwatch.observer/filing/0001829126-25-009432.json","markdown":"https://secwatch.observer/filing/0001829126-25-009432.md","text":"https://secwatch.observer/filing/0001829126-25-009432.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/0001829126-25-009432-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:53:39.985730+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}